PetVivo (NASDAQ:PETV – Get Free Report) is expected to post its resultson Thursday, November 12th. Analysts expect the company to post earnings of ($0.08) per share and revenue of $0.01 million for the quarter.
PetVivo Price Performance
NASDAQ:PETV opened at $0.58 on Tuesday. PetVivo has a 12 month low of $0.54 and a 12 month high of $1.44. The stock has a 50 day moving average of $0.72 and a two-hundred day moving average of $0.75. The company has a current ratio of 0.42, a quick ratio of 0.47 and a debt-to-equity ratio of 0.02. The firm has a market cap of $22.35 million, a P/E ratio of -1.29 and a beta of 1.41.
PetVivo Company Profile
PetVivo Holdings, Inc is a biomedical company focused on developing and commercializing medical therapeutics and devices for use in animals and, potentially, humans. The company’s technologies are designed to address conditions involving damaged or diseased tissue, with an emphasis on minimally invasive treatments.
PetVivo’s principal commercial product is Spryng with OsteoCushion Technology, an injectable product administered by veterinary professionals. It is intended to help manage lameness associated with osteoarthritis and other joint-related conditions in animals, including dogs and horses.
Read More
- Five stocks we like better than PetVivo
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
